Skip to main content
. 2022 Mar 2;13:844610. doi: 10.3389/fimmu.2022.844610

Table 1.

Characteristics of in-vitro-generated HIV-specific antibodies.

Sample ID ADCC activity (% PKH26 uptake) Latency reduction
Env C Env B % p24 reduction % NK cell activation
R1 33.4 34.4 64.99 23.67
R2 35 36.5 Not assessed
R3 43 31.9 62.50 50.27
R4 32.5 26.9 64.86 26.23
R5 27.9 53.8 Not assessed
R6 53.8 47.7 61.05 21.56
R7 48.2 33.4 56.37 31.05
R8 37.6 39.5 Not assessed
R9 62.1 67.8
Median 37.6 36.5 62.5 26.23
IQR 32.95–51 32.65–50.75 58.71–64.92 22.62–40.66
Range 27.9–62.1 26.9–67.8 56.37–64.99 21.56–50.27
NR1 8 5.9 9.86 7.14
NR2 9.7 2.5 17.81 13.15
Median 8.85 4.2 13.84 10.15

The table shows the characteristics of the in-vitro-generated antibodies, viz., ADCC activity (% PKH26 uptake) against Env C and Env B protein and the killing of Env-reactivated resting memory CD4+ T cells (% p24 reduction and simultaneous % NK cell activation). The percentages of NK cell activation in unstimulated control (background response) were subtracted from the frequencies of NK cell activation after the addition of antibodies to the respective Env-stimulated wells. “R” represents the antibodies generated from R-ADCC LTNPs, i.e., the individuals with plasma ADCC activity, and “NR” represents the antibodies generated from NR-ADCC LTNPs, i.e., the individuals with no plasma ADCC activity. The number corresponds to each LTNP. The median, interquartile range (IQR), and range values are mentioned for both R and NR antibodies.